1. Thyssen JP, Godoy-Gijon E, Elias PM. Ichthyosis vulgaris: the filaggrin mutation disease. Br J Dermatol 2013; 168 (6): 1155–66.
2. Li M, Cheng R, Shi M et al. Analyses of FLG mutation frequency and filaggrin expression in isolated ichthyosis vulgaris (IV) and atopic dermatitis-associated IV. Br J Dermatol 2013; 168 (6): 1335–8.
3. Ishida-Yamamoto A, Igawa S, Kishibe M. Order and disorder in corneocyte adhesion. J Dermatol 2011; 38 (7) 645–54.
4. Kороткий Н.Г., Тихомиров А.А., Гамаюнов Б.Н. Опыт применения масел для ванн «Бальнеум» и «Бальнеум Плюс» в комплексной терапии атопического дерматита и ихтиоза у детей. Рос. журн. кожных и венерических болезней. 2007; 3: 26–33.
5. Krug M, Oji V, Traupe H, Berneburg M. Ichthyoses. Part 2: Congenital ichthyoses. J Dtsch Dermatol Ges 2009; 7 (7): 577–88.
6. Oji V, Traupe H. Ichthyosis: clinical manifestations and practical treatment options. Am J Clin Dermatol 2009; 10 (6): 351–64.
7. Bellew S, Del Rosso JQ. Overcoming the Barrier Treatment of Ichthyosis:
A Combination-therapy Approach. J Clin Aesthet Dermatol 2010; 3 (7): 49–53.
8. Chapman MS. Vitamin А: history, current uses, and controversies. Semin Cutan Med Surg 2012; 31 (1): 11–6.
9. Russell M. Assessing the relationship between vitamin D3 and stratum corneum hydration for the treatment of xerotic skin. Nutrients 2012; 4 (9): 1213–8.
10. Tadini G, Giustini S, Milani M. Efficacy of topical 10% urea-based lotion in patients with ichthyosis vulgaris: a two-center, randomized, controlled, single-blind, right-vs.-left study in comparison with standard glycerol-based emollient cream. Curr Med Res Opin 2011; 27 (12): 2279–84.
11. Castello M, Milani M. Efficacy of topical hydrating and emollient lotion containing 10% urea ISDIN® plus dexpanthenol (Ureadin R×10) in the treatment of skin xerosis and pruritus in hemodialyzed patients: an open prospective pilot trial. G Ital Dermatol Venereol 2011; 146 (5): 321–5.
12. Luger T.A. Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate. J Eur Acad Dermatol Venerol 2011; 25: 251–8.
13. Кулагин В.И., Хамаганова И.В., Войнич З.В., Шекрота А.Г. Опыт применения мази «Адвантан» в детской дерматологической практике. Вестн. дерматологии и венерологии. 2000; (6): 50.
14. Khamaganova I. Alleviation of a severe pruritic flare-up in a 13-year-old child with chronic atopic dermatitis treated with methylprednisolone aceponate 0,1%. J Eur Acad Dermatol Venerol 2012; 26 (Suppl. 6): 20–1.
15. Peserico A, Städtler G, Sebastian M et al. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicenter, randomized double-blind, control study. Br J Dermatol 2008; 158: 801–7.
Авторы
И.В.Хамаганова1, Е.А.Ломакина2, Д.Ф.Кашеваров1, Ю.С.Федорова2
1. Кафедра кожных болезней и косметологии ФУВ ГБОУ ВПО РНИМУ им. Н.И.Пирогова Минздрава России, Москва;
2. Московский научно-практический центр дерматовенерологии и косметологии Департамента здравоохранения г. Москвы